• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期采血对维库溴铵药代动力学和药效学参数的重要性。

Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters.

作者信息

Ducharme J, Varin F, Bevan D R, Donati F

机构信息

Faculté de Pharmacie, Université de Montréal, Québec, Canada.

出版信息

Clin Pharmacokinet. 1993 Jun;24(6):507-18. doi: 10.2165/00003088-199324060-00006.

DOI:10.2165/00003088-199324060-00006
PMID:8099862
Abstract

The effect of early blood sampling on the description of the vecuronium pharmacokinetic-pharmacodynamic relationship was studied following a bolus injection. Sample collection every 10 sec during the first 2 min showed a high concentration peak at 30 to 40 sec, accounting for an important proportion of the total area under the plasma concentration-time curve (AUC). Neglecting it, using only blood samples drawn at 1 and 2 min (limited sampling), led to a significant overestimation of noncompartmentally derived values of mean residence time, clearance, volume of distribution at steady-state and rate of transfer of vecuronium into the effect compartment. Compartmental pharmacokinetics could not be applied to concentration-time curves constructed with early samples, but limited sampling data were fitted to a 2-compartment model. Derived compartmental pharmacokinetic and pharmacokinetic-pharmacodynamic parameters were similar to those obtained noncompartmentally with complete sampling every 10 sec, because back-extrapolation to time zero contributed to the increase in the AUC. However, compartmental analysis does not provide an accurate description of concentration changes following injection.

摘要

在静脉推注后,研究了早期采血对维库溴铵药代动力学-药效学关系描述的影响。在前2分钟内每隔10秒采集一次样本,结果显示在30至40秒出现一个高浓度峰值,该峰值在血浆浓度-时间曲线(AUC)下的总面积中占重要比例。忽略该峰值,仅使用在1分钟和2分钟采集的血样(有限采样),会导致对非房室模型得出的平均驻留时间、清除率、稳态分布容积以及维库溴铵向效应室的转运速率值的显著高估。房室药代动力学不适用于用早期样本构建的浓度-时间曲线,但有限采样数据可拟合到二室模型。推导得到的房室药代动力学和药代动力学-药效学参数与每隔10秒进行完整采样用非房室模型得到的参数相似,因为向时间零点的反向外推导致了AUC的增加。然而,房室分析并不能准确描述注射后的浓度变化。

相似文献

1
Importance of early blood sampling on vecuronium pharmacokinetic and pharmacodynamic parameters.早期采血对维库溴铵药代动力学和药效学参数的重要性。
Clin Pharmacokinet. 1993 Jun;24(6):507-18. doi: 10.2165/00003088-199324060-00006.
2
Pharmacokinetic origin of carbamazepine-induced resistance to vecuronium neuromuscular blockade in anesthetized patients.
Anesthesiology. 1996 Feb;84(2):330-9. doi: 10.1097/00000542-199602000-00010.
3
The pharmacokinetics of vecuronium in male and female patients.
Anesth Analg. 1998 Jun;86(6):1322-7. doi: 10.1097/00000539-199806000-00036.
4
Vecuronium in alcoholic liver disease: a pharmacokinetic and pharmacodynamic analysis.
Anesthesiology. 1988 May;68(5):771-6. doi: 10.1097/00000542-198805000-00016.
5
Neuromuscular block by vecuronium: simulation with a flow-volume model.
Eur J Anaesthesiol. 1994 Mar;11(2):65-74.
6
Cumulative characteristics of atracurium and vecuronium. A simultaneous clinical and pharmacokinetic study.阿曲库铵和维库溴铵的累积特性。一项临床与药代动力学同步研究。
Anesthesiology. 1994 Jul;81(1):59-68; discussion 27A.
7
[Comparative pharmacokinetics of pipecuronium bromide, pancuronium bromide and vecuronium bromide in anesthetized man].
Masui. 1990 Jul;39(7):882-9.
8
Are plasma concentration values necessary for pharmacodynamic modeling of muscle relaxants?血浆浓度值对于肌肉松弛剂的药效学建模是否必要?
Anesthesiology. 1997 Mar;86(3):567-75. doi: 10.1097/00000542-199703000-00008.
9
The pharmacodynamics and pharmacokinetics of the metabolite 3-desacetylvecuronium (ORG 7268) and its parent compound, vecuronium, in human volunteers.
J Pharmacol Exp Ther. 1994 Sep;270(3):1216-22.
10
Determination of vecuronium in blood by HPLC with UV and electrochemical detection: a pilot study in man.
Proc Natl Sci Counc Repub China B. 1991 Jul;15(3):186-90.

引用本文的文献

1
Simulation of the kinetics of neuromuscular block: implications for speed of onset.神经肌肉阻滞动力学模拟:对起效速度的影响。
Anesth Analg. 2013 Oct;117(4):792-802. doi: 10.1213/ANE.0b013e31827ee17f. Epub 2013 Mar 1.
2
Do plasma concentrations obtained from early arterial blood sampling improve pharmacokinetic/pharmacodynamic modeling?早期动脉血采样获得的血浆浓度是否能改善药代动力学/药效学建模?
J Pharmacokinet Biopharm. 1999 Apr;27(2):173-90. doi: 10.1023/a:1020653922866.
3
Clinical pharmacokinetics of cisatracurium besilate.苯磺顺阿曲库铵的临床药代动力学

本文引用的文献

1
Kinetics of binding of [3H]acetylcholine to Torpedo postsynaptic membranes: association and dissociation rate constants by rapid mixing and ultrafiltration.[3H]乙酰胆碱与电鳐突触后膜结合的动力学:通过快速混合和超滤测定结合和解离速率常数
Biochemistry. 1980 Nov 11;19(23):5353-8. doi: 10.1021/bi00564a032.
2
Artery-to-muscle onset time for neuromuscular blocking drugs.
Br J Anaesth. 1980 Apr;52(4):403-7. doi: 10.1093/bja/52.4.403.
3
Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.理解剂量-效应关系:药代动力学-药效学模型的临床应用
Clin Pharmacokinet. 1999 Jan;36(1):27-40. doi: 10.2165/00003088-199936010-00003.
4
Determination of the distribution volume that can be used to calculate the intravenous loading dose.用于计算静脉注射负荷剂量的分布容积的测定。
Clin Pharmacokinet. 1998 Jul;35(1):1-7. doi: 10.2165/00003088-199835010-00001.
5
Pharmacokinetic-pharmacodynamic modeling of doxacurium: effect of input rate.多沙库铵的药代动力学-药效学建模:输入速率的影响。
J Pharmacokinet Biopharm. 1997 Feb;25(1):23-37. doi: 10.1023/a:1025715626164.
6
An extended pharmacokinetic/pharmacodynamic model describing quantitatively the influence of plasma protein binding, tissue binding, and receptor binding on the potency and time course of action of drugs.一个扩展的药代动力学/药效学模型,用于定量描述血浆蛋白结合、组织结合和受体结合对药物效力和作用时间过程的影响。
J Pharmacokinet Biopharm. 1996 Feb;24(1):45-77. doi: 10.1007/BF02353510.
7
Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.维库溴铵和新斯的明在蒙特利尔和巴黎的神经肌肉效应。
Can J Anaesth. 1994 Oct;41(10):908-12. doi: 10.1007/BF03010933.
Clin Pharmacokinet. 1981 Nov-Dec;6(6):429-53. doi: 10.2165/00003088-198106060-00002.
4
Simultaneous modeling of pharmacokinetics and pharmacodynamics with a nonparametric pharmacodynamic model.使用非参数药效学模型对药代动力学和药效学进行同步建模。
Clin Pharmacol Ther. 1984 Jun;35(6):733-41. doi: 10.1038/clpt.1984.104.
5
Pharmacokinetics and pharmacodynamics of vecuronium (ORG NC45) and pancuronium in anesthetized humans.
Anesthesiology. 1983 May;58(5):405-8. doi: 10.1097/00000542-198305000-00002.
6
Pharmacokinetics of Org NC45 (norcuron) in patients with and without renal failure.Org NC45(诺库溴铵)在有和没有肾衰竭的患者中的药代动力学。
Br J Anaesth. 1981 Oct;53(10):1049-53. doi: 10.1093/bja/53.10.1049.
7
Pharmacokinetics and pharmacodynamics of Org NC 45 in man.
Br J Anaesth. 1980;52 Suppl 1:37S-41S. doi: 10.1093/bja/52.suppl_1.37s.
8
The emergence of ORG NC 45, 1- [2 beta,3 alpha,5 alpha,16 beta,17 beta)-3, 17-bis(acetyloxy)-2-(1-piperidinyl)-androstan-16-yl]-1-methylpiperidinium bromide, from the pancuronium series.
Br J Anaesth. 1980;52 Suppl 1:3S-9S. doi: 10.1093/bja/52.suppl_1.3s.
9
Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric kinetic and dynamic models.使用非参数动力学和动力学模型对药代动力学和药效学进行同时建模。
Clin Pharmacol Ther. 1986 Jul;40(1):86-93. doi: 10.1038/clpt.1986.143.
10
The pharmacodynamics and pharmacokinetics of vecuronium in patients anesthetized with isoflurane with normal renal function or with renal failure.
Anesthesiology. 1988 Aug;69(2):227-31. doi: 10.1097/00000542-198808000-00012.